Motif Neurotech Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 20

Motif Neurotech General Information

Description

Operator of a therapeutic brain-computer interface company intended for treatment-resistant depression. The company uses proprietary wireless data and power solutions to miniaturize implants, reduce surgical burden, and provide personalized treatments that restore hope and improve quality of life, enabling patients to repair neural circuits with minimally invasive electronic therapies.

Contact Information

Website
www.motifneuro.tech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2450 Holcombe Boulevard
  • Houston, TX 77021
  • United States
+1 (832)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech
Corporate Office
  • 2450 Holcombe Boulevard
  • Houston, TX 77021
  • United States
+1 (832)

Motif Neurotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Motif Neurotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC 07-Oct-2026 Completed Pre-Clinical Trials
7. Grant 20-Jan-2025 Completed Pre-Clinical Trials
6. Accelerator/Incubator 09-Aug-2024 Completed Pre-Clinical Trials
5. Early Stage VC (Series A) 12-Jan-2024 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Mar-2023 Completed Startup
3. Grant Completed Startup
2. Grant $50K Completed Startup
1. University Spin-Out 01-Jan-2022 Completed Startup
To view Motif Neurotech’s complete valuation and funding history, request access »

Motif Neurotech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
Series A 21,569,503 $0.000100 $0.9 $0.9 1x $0.9 50.02%
To view Motif Neurotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Motif Neurotech Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 16

    Pending

  • Expiring in next 12 mo

Motif Neurotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260295258-A1 Closed-loop externally powered electrical cortical stimulations (xcs) Pending 25-Mar-2025
WO-2026206600-A1 Closed-loop externally powered electrical cortical stimulations (xcs) Pending 25-Mar-2025
US-20260301912-A1 Systems and methods for dosing externally powered cortical stimulation (xcs) therapy Pending 25-Mar-2025
WO-2026206599-A1 Systems and methods for dosing externally powered cortical stimulation (xcs) therapy Pending 25-Mar-2025
US-20260295268-A1 Systems and methods for improving externally powered cortical stimulation (xcs) waveforms Pending 25-Mar-2025 A61N1/36139
To view Motif Neurotech’s complete patent history, request access »

Motif Neurotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Motif Neurotech Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Features Capital Venture Capital Minority
One Giant Leap Ventures Venture Capital Minority
Satori Capital PE/Buyout Minority
Advanced Research + Invention Agency Government
NeuroTech Harbor Accelerator/Incubator Minority
You’re viewing 5 of 20 investors. Get the full list »

Ready to get started?

Request a free trial

Motif Neurotech FAQs

  • When was Motif Neurotech founded?

    Motif Neurotech was founded in 2022.

  • Where is Motif Neurotech headquartered?

    Motif Neurotech is headquartered in Houston, TX.

  • What is the size of Motif Neurotech?

    Motif Neurotech has 31 total employees.

  • What industry is Motif Neurotech in?

    Motif Neurotech’s primary industry is Therapeutic Devices.

  • Is Motif Neurotech a private or public company?

    Motif Neurotech is a Private company.

  • What is Motif Neurotech’s current revenue?

    The current revenue for Motif Neurotech is .

  • How much funding has Motif Neurotech raised over time?

    Motif Neurotech has raised $18.9M.

  • Who are Motif Neurotech’s investors?

    Features Capital, One Giant Leap Ventures, Satori Capital, Advanced Research + Invention Agency, and NeuroTech Harbor are 5 of 20 investors who have invested in Motif Neurotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process